Agentforce Adoption Rises: Can It Be Salesforce's Next Growth Engine?

Salesforce said Agentforce ARR reached about $800 million at the end of fiscal 2026, up 169% year over year, with more than 29,000 deals and AI-related ARR surpassing $2.9 billion, up more than 200%. Current remaining performance obligation rose 16% to $35.1 billion, and management guided fiscal 2027 revenue growth to 10-11% versus a 10.9% consensus estimate. Despite the operational momentum, the stock is still down 35% over the past year and trades at 12.84x forward earnings versus 28.77x for the industry.

Analysis

CRM’s AI monetization is beginning to look less like a feature upgrade and more like a packaging reset: if Agentforce keeps converting installed-base accounts, the company can re-rate more on ACV expansion and renewal durability than on net-new seat growth. The important second-order effect is that AI attach can improve gross retention without requiring a broad uplift in enterprise IT budgets, which makes the spend easier to defend in a softer macro tape. That also shifts CRM’s competitive battleground from CRM workflow share to “where does the agent layer live,” a more strategic fight that could pressure point solutions and smaller automation vendors first.

The market is likely still underestimating the operating leverage if AI ARR keeps compounding inside the existing base. Once a product is embedded in core workflows, churn drops and pricing power migrates from user licenses to workflow orchestration, which can support multiple expansion even if topline growth remains only low-double-digit. The risk is that the current enthusiasm front-loads expectations before true seat-level or usage-based economics are proven; if pilots fail to convert into broad deployment over the next 2-3 quarters, the narrative can unwind quickly.

For MSFT and NOW, the implication is not that they lose outright, but that CRM’s progress raises the bar for differentiated AI workflow monetization across enterprise software. MSFT has distribution advantages, but CRM’s domain-specific data plus customer intimacy may make its agent layer stickier in sales/service use cases than horizontal copilots. NOW is the cleaner “AI workflow ROI” peer; if CRM starts converting its install base faster, NOW could see relative multiple compression as investors rotate to the platform with the strongest incremental monetization curve. The contrarian take: the stock’s large underperformance means some of this AI option value is already discounted, so the better short term risk/reward may be in relative value rather than outright longs.

Key Decisions for Investors

• Go long CRM vs NOW over the next 1-3 months via a pair trade: CRM should benefit more from installed-base cross-sell reacceleration, while NOW’s valuation leaves less room if CRM’s agent monetization proves durable.
• Buy CRM 6-12 month calls on pullbacks rather than chasing strength; the setup is better as a convexity trade on evidence of usage conversion over the next two earnings cycles, not as a momentum long.
• If you want cleaner AI enterprise exposure, pair long CRM with short a basket of smaller automation/agent names that lack distribution depth; the thesis is that CRM’s embedded customer base wins the first wave of enterprise agent budgets.
• Reduce tactically if CRM fails to show continued sequential deal growth or early renewals in the next 1-2 quarters; that would be the fastest signal that the AI ARR story is outrunning real budget reallocation.
• For a lower-risk expression, own CRM against MSFT only if you believe vertical workflow monetization will outpace horizontal copilots over 6-12 months; otherwise MSFT remains the safer quality compounder.